Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Uropathogenic Escherichia coli (UPEC) fimbrial adhesins are critical virulence factors located at the tips of hair-like appendages called fimbriae or pili. These proteins, most notably the FimH adhesin of Type 1 fimbriae and the PapG adhesin of P fimbriae, mediate the specific attachment of bacteria to host receptors on the uroepithelium (UniProt P08191, P07110). FimH specifically recognizes terminal D-mannose residues on glycoproteins like Uroplakin Ia, which is essential for the colonization of the bladder and the development of cystitis (PubMed: 29158460). PapG binds to Gal(alpha1-4)Gal-containing glycolipids, a process primarily associated with the infection of the upper urinary tract and pyelonephritis (PubMed: 11544341). By facilitating stable adhesion, these proteins allow UPEC to resist the mechanical flushing of urine and initiate invasion into host cells. Consequently, fimbrial adhesins are major therapeutic targets for anti-adhesive drugs, such as mannosides and small-molecule inhibitors like GSK3882347 and Siboflanstat, which aim to prevent or treat infections without inducing the selective pressure associated with traditional antibiotics (PubMed: 32814554).
Competitive inhibition of bacterial adhesion to host urothelial receptors by mimicking natural carbohydrate ligands, thereby preventing colonization and facilitating bacterial clearance.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uropathogenic Escherichia coli fimbrial adhesin (FimH).